Clinical Trial Update: TRIAD - Treatment of Insomnia and Depression [Phase 2, Phase 3]

View source ↗

Summary

The TRIAD program evaluating treatment for insomnia and depression has completed Phase 2 and Phase 3 trials, with results posted in December 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia
• Major Depressive Disorder

Snippet

Sponsor: Stanford University | Conditions: Sleep Initiation and Maintenance Disorders, Depression | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2016-12-05